JP Morgan Chase
ASXC

JP Morgan Chase’s Asensus Surgical, Inc. ASXC Stock Holding History

JP Morgan Chase’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-87,506
Closed -$29.1K – 7790
2024
Q2 		$29.1K Buy
87,506
+18,462
+27% +$4.98K ﹤0.01% 6041
2024
Q1 		$15.9K Sell
69,044
-115,670
-63% -$33.6K ﹤0.01% 6271
2023
Q4 		$58.9K Sell
184,714
-9,148
-5% -$2.36K ﹤0.01% 5950
2023
Q3 		$52.3K Buy
193,862
+147,715
+320% +$53.7K ﹤0.01% 5789
2023
Q2 		$23.3K Sell
46,147
-967
-2% -$578 ﹤0.01% 5891
2023
Q1 		$31K Buy
+47,114
New +$31.9K ﹤0.01% 5863
2022
Q4 		– Sell
-71,128
Closed -$32K – 7112
2022
Q3 		$32K Buy
+71,128
New +$37.1K ﹤0.01% 5685
2022
Q2 		– Sell
-109,736
Closed -$69K – 6992
2022
Q1 		$69K Buy
109,736
+19,524
+22% +$15K ﹤0.01% 5666
2021
Q4 		$100K Buy
90,212
+4,012
+5% +$6.2K ﹤0.01% 5683
2021
Q3 		$159K Sell
86,200
-3,633
-4% -$8.16K ﹤0.01% 5352
2021
Q2 		$285K Buy
+89,833
New +$225K ﹤0.01% 5045
2020
Q4 		– Sell
-3
Closed – – 6006
2020
Q3 		$0 Sell
3
-145
-98% -$56 ﹤0.01% 5856
2020
Q2 		$0 Sell
148
-5,737
-97% -$2.77K ﹤0.01% 5773
2020
Q1 		$2K Buy
5,885
+438
+8% +$457 ﹤0.01% 5196
2019
Q4 		$8K Sell
5,447
-20
-0.4% -$69 ﹤0.01% 5425
2019
Q3 		$44K Sell
5,467
-136,535
-96% -$1.86M ﹤0.01% 5233
2019
Q2 		$2.36M Sell
142,002
-495,316
-78% -$10.8M ﹤0.01% 3268
2019
Q1 		$19.7M Buy
637,318
+42,870
+7% +$1.44M ﹤0.01% 1547
2018
Q4 		$17.5M Buy
594,448
+5,174
+0.9% +$235K ﹤0.01% 1579
2018
Q3 		$44.4M Buy
589,274
+51,981
+10% +$3.52M 0.01% 1082
2018
Q2 		$30.5M Sell
537,293
-22,594
-4% -$823K 0.01% 1285
2018
Q1 		$12.4M Buy
559,887
+11,687
+2% +$267K ﹤0.01% 1871
2017
Q4 		$13.8M Buy
548,200
+222,800
+68% +$6.86M ﹤0.01% 1866
2017
Q3 		$5.67M Sell
325,400
-213
-0.1% -$2.48K ﹤0.01% 2470
2017
Q2 		$3M Buy
325,613
+213
+0.1% +$2.03K ﹤0.01% 2806
2017
Q1 		$5.12M Hold
325,400
– – ﹤0.01% 2409
2016
Q4 		$5.5M Hold
325,400
– – ﹤0.01% 2373
2016
Q3 		$7.15M Hold
325,400
– – ﹤0.01% 2003
2016
Q2 		$5.16M Buy
325,400
+76,923
+31% +$2.41M ﹤0.01% 2272
2016
Q1 		$13.7M Sell
248,477
-39,985
-14% -$1.71M ﹤0.01% 1585
2015
Q4 		$9.3M Hold
288,462
– – ﹤0.01% 1866
2015
Q3 		$8.47M Sell
288,462
-199
-0.1% -$7.38K ﹤0.01% 1891
2015
Q2 		$11.3M Buy
+288,661
New +$13.3M ﹤0.01% 1842
2015
Q1 		– Sell
-8,630
Closed -$326K – 4311
2014
Q4 		$326K Sell
8,630
-163
-2% -$6.73K ﹤0.01% 3833
2014
Q3 		$499K Sell
8,793
-619
-7% -$33.4K ﹤0.01% 3667
2014
Q2 		$616K Buy
+9,412
New +$544K ﹤0.01% 3042

Other funds holding ASXC

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

JP Morgan Chase's ASXC Position: Q3 2024 in Review

JP Morgan Chase sold out of Asensus Surgical, Inc. (ASXC) in Q3 2024, closing a stake of 87,506 shares — an estimated $29.1K sold.

JP Morgan Chase first reported a position in ASXC in Q2 2014 and held it in 36 quarters. The position peaked at $44.4M in Q3 2018. 1 fund tracked by Wall St. Rank holds ASXC as of Q3 2024.

  • JP Morgan Chase reported no remaining Asensus Surgical, Inc. position as of Q3 2024 after selling out during the quarter.
  • JP Morgan Chase sold 87,506 Asensus Surgical, Inc. shares in Q3 2024, an estimated $29.1K.
  • JP Morgan Chase first reported a position in Asensus Surgical, Inc. in Q2 2014 and held it in 36 quarters.
  • JP Morgan Chase's Asensus Surgical, Inc. position peaked at $44.4M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2024.

Based on JP Morgan Chase's 13F filing for Q3 2024, filed 8 Nov 2024.